152 related articles for article (PubMed ID: 33001270)
1. The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro.
Yamaguchi M; Murata T; Ramos JW
J Cancer Res Clin Oncol; 2021 Feb; 147(2):339-350. PubMed ID: 33001270
[TBL] [Abstract][Full Text] [Related]
2. The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells.
Yamaguchi M; Murata T; Ramos JW
Anticancer Drugs; 2021 Jun; 32(5):558-566. PubMed ID: 33595948
[TBL] [Abstract][Full Text] [Related]
3. The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases.
Yamaguchi M; Murata T; Shoji M; Weitzmann MN
Int J Oncol; 2015 Oct; 47(4):1563-71. PubMed ID: 26238204
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells.
Yamaguchi M; Murata T; Ramos JW
Prostate; 2022 Jun; 82(10):1025-1039. PubMed ID: 35365850
[TBL] [Abstract][Full Text] [Related]
5. Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells.
Yamaguchi M; Osuka S; Murata T; Ramos JW
Transl Oncol; 2021 Jan; 14(1):100955. PubMed ID: 33232921
[TBL] [Abstract][Full Text] [Related]
6. The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcin.
Yamaguchi M; Murata T; Ramos JW
Mol Cell Biochem; 2020 Sep; 472(1-2):173-185. PubMed ID: 32591915
[TBL] [Abstract][Full Text] [Related]
7. The marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol suppresses growth, migration and invasion and stimulates death of metastatic human prostate cancer cells: targeting diverse signaling processes.
Yamaguchi M; Yosiike K; Watanabe H; Watanabe M
Anticancer Drugs; 2022 Jun; 33(5):424-436. PubMed ID: 35324521
[TBL] [Abstract][Full Text] [Related]
8. An aryl hydrocarbon receptor agonist suppresses the growth of human umbilical vein endothelial cells in vitro: Potent effect with polyunsaturated fatty acids.
Yamaguchi M; Hankinson O
Int J Exp Pathol; 2020 Dec; 101(6):248-263. PubMed ID: 32985761
[TBL] [Abstract][Full Text] [Related]
9. The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.
Yamaguchi M
Mol Cell Biochem; 2016 Oct; 421(1-2):193-203. PubMed ID: 27573001
[TBL] [Abstract][Full Text] [Related]
10. Phytocomponent p-hydroxycinnamic acid stimulates mineralization in osteoblastic MC3T3-E1 cells.
Yamaguchi M; Lai YL; Uchiyama S; Nakagawa T
Int J Mol Med; 2008 Sep; 22(3):287-91. PubMed ID: 18698486
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory macrophages repress the growth of bone metastatic human prostate cancer cells via TNF-α and IL-6 signaling: Involvement of cell signaling regulator regucalcin.
Yamaguchi M; Hashimoto K; Jijiwa M; Murata T
Cell Signal; 2023 Jul; 107():110663. PubMed ID: 37001596
[TBL] [Abstract][Full Text] [Related]
12. Aromatic Hydrocarbon Receptor Suppresses Prostate Cancer Bone Metastasis Cells-Induced Vasculogenesis of Endothelial Progenitor Cells under Hypoxia.
Huang S; Guo Y; Jacobi A; Li Z; Huang S; He J; Liu X; Tang Y
Cell Physiol Biochem; 2016; 39(2):709-20. PubMed ID: 27448695
[TBL] [Abstract][Full Text] [Related]
13. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
[TBL] [Abstract][Full Text] [Related]
14. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
[TBL] [Abstract][Full Text] [Related]
15. Effect of PI3K/Akt Signaling Pathway on the Process of Prostate Cancer Metastasis to Bone.
Zhu W; Hu X; Xu J; Cheng Y; Shao Y; Peng Y
Cell Biochem Biophys; 2015 May; 72(1):171-7. PubMed ID: 27040945
[TBL] [Abstract][Full Text] [Related]
16. Bioactive flavonoid p-hydroxycinnamic acid stimulates osteoblastogenesis and suppresses adipogenesis in bone marrow culture.
Yamaguchi M; Baile CA; Zhu S; Shoji M
Cell Tissue Res; 2013 Dec; 354(3):743-50. PubMed ID: 24026435
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Regucalcin Suppresses the Growth, Migration, Invasion, and Adhesion of Metastatic Human Prostate Cancer Cells.
Yamaguchi M; Murata T; Ramos JW
Oncology; 2022; 100(7):399-412. PubMed ID: 35340010
[TBL] [Abstract][Full Text] [Related]
18. Aryl Hydrocarbon Receptor Suppresses the Prostate Cancer LNCaP Cell Growth and Invasion by Promoting DNA Damage Response Under Oxidative Stress.
Yu JS; Leng PF; Li YF; Wang YQ; Wang Y; An RH; Qi JP
DNA Cell Biol; 2017 Nov; 36(11):1010-1017. PubMed ID: 28972393
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
20. Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
Liang W; Wang F; Chen Q; Dai J; Escara-Wilke J; Keller ET; Zimmermann J; Hong N; Lu Y; Zhang J
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1999-2012. PubMed ID: 31172267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
